project id: TCGA-SKCM; case submitter id: TCGA-EB-A5KH; analyte type: DNA; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.05; rna integrity number: 9.6; age at index: 55; days to birth: -20424; days to death: 619; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Dead; year of birth: 1956; age at diagnosis: 20424; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T0; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 543.0; icd 10 code: C77.4; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph nodes of inguinal region or leg; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 648; days to sample procurement: 0; initial weight: 830.0; portion submitter id: TCGA-EB-A5KH-06A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 85.0;